Genentech Sues Apotex Over Generic Valcyte

Law360, San Francisco (May 19, 2011, 6:21 PM EDT) -- Roche Holding Ltd. subsidiary Genentech Inc. sued Apotex Inc. in California on Tuesday, accusing it of infringing a patent covering the anti-viral drug Valcyte.

Genentech and Roche Palo Alto LLC's complaint claims Apotex infringed U.S. Patent Number 6,083,953 by seeking U.S. Food and Drug Administration approval for a generic version of Valcyte, and seeks to block the Canadian drugmaker from selling its product in the U.S. before that patent expires.

“Apotex threatens to market and sell the Apotex generic product in California and elsewhere in the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.